Daniel Morales

View Scopus Profile

h-index

Research activity per year

91 Article
6 Letter
4 Comment/debate
3 Preprint
More

3 results

Filter

2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study
LEGEND-T2DM collaboration, Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Camargos, A. P., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., Blacketer, C., Chai, Y., Chattopadhyay, S., Cook, M., Dorr, D. A., Duarte-Salles, T., DuVall, S. L., Falconer, T. & French, T. E. & 35 others, Hanchrow, E. E., Kaur, G., Lau, W. C., Li, J., Li, K., Liu, Y., Lu, Y., Man, K. K., Matheny, M. E., Mathioudakis, N., McLeggon, J.-A., McLemore, M. F., Minty, E., Morales, D. R., Nagy, P., Ostropolets, A., Pistillo, A., Phan, T.-P., Pratt, N., Reyes, C., Richter, L., Ross, J., Ruan, E., Seager, S. L., Simon, K. R., Viernes, B., Yang, J., Yin, C., You, S. C., Zhou, J. J., Ryan, P. B., Schuemie, M. J., Krumholz, H. M., Hripcsak, G. & Suchard, M. A. (Lead / Corresponding author), 8 Feb 2024, medRxiv, 34 p.
Research output: Working paper/Preprint › Preprint

File
19 Downloads (Pure)
2023
A Digital Tool for Clinical Evidence-Driven Guideline Development: Studying Properties of Trial Eligible and Ineligible Populations
Mumtaz, S., McMinn, M., Cole, C., Gao, C., Hall, C., Guignard-Duff, M., Huang, H., McAllister, D. A., Morales, D. R., Jefferson, E. (Lead / Corresponding author) & Guthrie, B., 1 Sept 2023, JMIR Publications.
Research output: Working paper/Preprint › Preprint
2021
Assessing the impact of SIGN 136 on opioid prescribing rates in Scotland: An interrupted time series analysis
Hebert, H. L. (Lead / Corresponding author), Morales, D. R., Torrance, N., Smith, B. H. & Colvin, L. A., 23 Feb 2021, Cold Spring Harbor Laboratory: medRxiv, 18 p.
Research output: Working paper/Preprint › Preprint

Open Access

Morales, Daniel

Research output

Search results

Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

A Digital Tool for Clinical Evidence-Driven Guideline Development: Studying Properties of Trial Eligible and Ineligible Populations

Assessing the impact of SIGN 136 on opioid prescribing rates in Scotland: An interrupted time series analysis